Lasa Supergenerics Limited — Board Meeting, 21-05-2025: Outcome of Board Meeting

Lasa Supergenerics has announced a board meeting on which it approved the appointment of Mr. Prathamesh Chalke as an Additional Executive Director and Occupier of all company units. With strong pharma production expertise and a central role in operations, Chalke’s addition to the board (pending member approval) signals a focus on strengthening leadership and manufacturing oversight. No other financial or strategic updates were shared.